Product

Popular information

Diabetes medication Linagliptin 668270-12-0

【Alias】 8-[(3R) -3-amino-1-piperidinyl] -7- (2-butynyl) -3,7-dihydro-3-methyl-1-[(4-methyl- 2-quinazolinyl) methyl] -1H-purine-2,6-dione
【Catalog number】AP4700
【CAS #】668270-12-0
【Molecular formula】C16H20F6N5O6P
【Product Brief】US-DMF No. 29692 Lilaliptin, English name Linagliptin, American Chemical Abstracts registration number cas 668270-12-0.
English Name : Linagliptin
CAS# : 668270-12-0
产品描述
[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[[产品参数, 参数]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]]

Linagliptin
CAS 668270-12-0
US-DMF No. 29692

Alias 8-[(3R) -3-amino-1-piperidinyl] -7- (2-butynyl) -3,7-dihydro-3-methyl-1-[(4-methyl- 2-quinazolinyl) methyl] -1H-purine-2,6-dione

Catalog number AP4700

CAS # 668270-12-0

Molecular formula C25H28N8O2

Molecular weight 472.54

Structural formula

威智医药

Product introduction

CAS 668270-12-0

US-DMF No. 29692 Lilaliptin, English name Linagliptin, American Chemical Abstracts registration number cas 668270-12-0.

Lillaritin (cas 668270-12-0) was approved by the FDA on May 2, 2011 to improve dietary and exercise control of blood glucose levels in people with type 2 diabetes. Lilaridine improves patients' glycemic control by inhibiting dipeptidyl peptidase-4 (DPP-4).

扫二维码用手机看
未找到相应参数组,请于后台属性模板中添加
search
Confirm
Close